Publication | Closed Access

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

VaccinationVaccine SafetyCross-protectionVaccine DevelopmentImmunologyVirologyVaccine EfficacyInfluenza VaccineHealthy AdultsMedicineInfluenza Vaccines